Mayer L
Division of Clinical Immunology, Mt. Sinai Medical Center, New York, New York 10029-6574, USA.
J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S4-12. doi: 10.1097/00005176-200001001-00002.
The intestine is the largest lymphoid organ in the body by virtue of lymphocyte numbers and quantity of immunoglobulin produced. This is largely related to the enormous antigen load to which these cells are exposed on a daily basis. However, despite this, the mucosa-associated lymphoid tissue appears to be regulated by unique mechanisms, and this is reflected in specific phenomena (oral tolerance, controlled or physiologic inflammation) as well as unusual lymphoid populations (intraepithelial lymphocytes) that respond to alternative pathways of activation. This, coupled with the existence of novel antigen-presenting cells (intestinal epithelial cells) sets the scene for distinct immune responses. It is these distinct regulatory factors that support immunosuppression or tolerance rather than active immunity at a site juxtaposed to the external environment. This review defines these novel interactions and suggests how alteration in normal function may result in allergic or inflammatory responses. A clearer understanding of mucosal immunoregulation may lead to new therapeutic approaches for these diseases.
凭借淋巴细胞数量和产生的免疫球蛋白量,肠道是体内最大的淋巴器官。这在很大程度上与这些细胞每天所接触的大量抗原负荷有关。然而,尽管如此,黏膜相关淋巴组织似乎受独特机制调控,这体现在特定现象(口服耐受、可控或生理性炎症)以及对替代激活途径作出反应的异常淋巴群体(上皮内淋巴细胞)中。这一点,再加上新型抗原呈递细胞(肠上皮细胞)的存在,为独特的免疫反应创造了条件。正是这些独特的调节因子在与外部环境相邻的部位支持免疫抑制或耐受,而非主动免疫。本综述定义了这些新型相互作用,并提出正常功能的改变可能如何导致过敏或炎症反应。对黏膜免疫调节的更清晰理解可能会带来针对这些疾病的新治疗方法。